<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 4 )*
----------
SHELBY WILLIAMS INDUSTRIES, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock $.05 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
822135 10 9
- --------------------------------------------------------------------------------
(CUSIP Number)
Walter Roth, D'Ancona & Pflaum
30 North LaSalle Street, Suite 2900, Chicago, IL 60602 Tel.# (312) 580-2020
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
April 2, 1997
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
NOTE. Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 pages
<PAGE>
SCHEDULE 13D
CUSIP NO. 822135 10 9 PAGE 2 OF 5 PAGES
------------ --- ---
- -------------------------------------------------------------------------------
(1) NAMES OF REPORTING PERSONS. S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
MANFRED STEINFELD
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) SOURCE OF FUNDS*
SC
- -------------------------------------------------------------------------------
(5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
N/A
- -------------------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------
NUMBER OF SHARES (7) SOLE VOTING POWER
BENEFICIALLY OWNED 1,000,646
BY EACH REPORTING --------------------------------------------------
PERSON WITH (8) SHARED VOTING POWER
45,546
--------------------------------------------------
(9) SOLE DISPOSITIVE POWER
1,000,646
--------------------------------------------------
(10) SHARED DISPOSITIVE POWER
45,546
- -------------------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,046,192
- -------------------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* /X/
- -------------------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.2
- -------------------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
2
<PAGE>
ITEM 1. SECURITY AND ISSUER.
This Amendment No. 4 to Schedule 13D relates to the shares of common
stock, $.05 par value of Shelby Williams Industries, Inc. (the "Company"). The
address of the principal executive offices of the Company is Suite 11-111,
Merchandise Mart, Chicago, Illinois 60654.
ITEM 2. IDENTITY AND BACKGROUND.
(a) Manfred Steinfeld ("Steinfeld").
(b) Suite 11-111, Merchandise Mart, Chicago, Illinois 60654.
(c) Steinfeld is Chairman of the Executive Committee of the Company,
whose principal business is the designing, manufacturing, and distribution of
products for the contract furniture business.
(d) During the last five years, Steinfeld has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) During the last five years, Steinfeld has not been a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
(f) Steinfeld is a citizen of the United States of America.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The funds used for the purchase reported herein (see Item 5(c) below)
were contributed to the Company's ESOP described below from the Company's
working capital and were not borrowed. The total amount of such funds was
$68,750.
ITEM 4. PURPOSE OF TRANSACTION.
The purchase reported herein was made by the ESOP pursuant to the
Company's contribution to the ESOP. Steinfeld, individually and as trustee,
may, in the future, purchase additional shares of the Company's common stock or
dispose of such shares by sale, gift or otherwise. Steinfeld has no present
plans or proposals which relate to or would result in any actions listed in
paragraphs (a) through (j) of Item 4 of Steinfeld's original Schedule 13D.
Steinfeld reserves the right to adopt any such plans or proposals in the future.
3
<PAGE>
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) Steinfeld owns beneficially 1,046,192 shares (11.2%) of the
Company's outstanding common stock, consisting of the following: (i) 1,000,646
shares owned by Steinfeld; (ii) 488 shares owned by The Steinfeld Foundation, an
Illinois not-for-profit corporation with three directors; and (iii) 45,058
shares held by Steinfeld as one of four trustees of the Company's Employee Stock
Ownership Plan ("ESOP"). Steinfeld disclaims beneficial ownership of the shares
listed in (ii) and (iii) of the preceding sentence. The figures in this
paragraph exclude 25,054 shares owned by Fern Steinfeld (wife of Steinfeld), as
to which Steinfeld disclaims beneficial ownership pursuant to Rule 13d-4.
(b) Steinfeld has sole power to vote and dispose of 1,000,646 shares;
shared voting and investment power with Fern Steinfeld and Paul N. Steinfeld
(son of Steinfeld) as to 488 shares owned by The Steinfeld Foundation, of which
Steinfeld, Fern Steinfeld and Paul N. Steinfeld are trustees; and shared voting
and investment power with Paul N. Steinfeld, Robert P. Coulter and Sam Ferrell,
trustees, as to the 45,058 shares held by the trustees of the ESOP described in
paragraph (a) above. The business address of Fern Steinfeld is the same as
Steinfeld, and her present principal occupation is housewife. The business
address of each of Paul N. Steinfeld, Robert P. Coulter and Sam Ferrell is
Shelby Williams Industries, Inc., 150 Shelby Williams Drive, Morristown,
Tennessee 37813, and the present principal occupation of each such person is as
an executive officer of the Company. All of the persons identified in this
paragraph are citizens of the United States of America and none has been
involved during the last five years in any of the matters described in Item 2(d)
or (e).
(c) Since February 1, 1997, the ESOP purchased 50,000 shares of the
Company's common stock as follows:
NUMBER OF SHARES PRICE
DATE PURCHASED PER SHARE
-------- --------- ---------
4/2/96 5,000 $13.75
The purchase by the ESOP was made from underwriters in an underwritten
public offering of the Company's stock (SEC Reg. No. 333-22741).
Since February 1, 1997, the following dispositions of Company stock were
made:
(i) On February 3, 1997, Steinfeld disposed of 64,000 shares of the
Company's common stock by gift.
(ii) On April 2, 1997, Steinfeld sold 1,100,000 shares of the
Company's common stock to underwriters at a price of $13.00 per
share.
(ii) On April 2, 1997, The Fern and Manfred Steinfeld Charitable
Remainder Trust UTA 10/17/95 (the "CRT") sold 331,000 shares of
the Company's common stock to underwriters at a price of $13.00
per share. Steinfeld is settlor and a trustee of
4
<PAGE>
the CRT with sole power as trustee to vote and dispose of the
shares sold by the CRT; Fern Steinfeld is the other trustee of
the CRT.
(iv) On April 7, 1997, Steinfeld sold 50,000 shares of the Company's
common stock at a price of $13.00 per share to underwriters
exercising a portion of an over-allotment option.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
The sales to underwriters described above were pursuant to an
underwriting agreement dated March 26, 1997, among the Company, Steinfeld and
the CRT as selling stockholders and the underwriters, a copy of which agreement
is attached as Exhibit 1 hereto.
By letter agreement dated March 4, 1997, a copy of which letter agreement
is attached as Exhibit 2 hereto, Steinfeld and the other executive officers of
the Company agreed that they will not, without the prior written approval of
Lazard Freres & Co. LLC, directly or indirectly, offer, sell, offer to sell,
contract to sell, pledge, grant any option to purchase, or otherwise sell or
dispose (or announce any offer, sale, offer of sale, contract of sale, pledge,
grant of an option to purchase or other sale or disposition) of any shares of
capital stock of the Company, or any securities convertible into, or
exchangeable or exercisable for, shares of capital stock of the Company for a
period of 180 days following the date of the Prospectus relating to the
underwritten offering referred to herein. The date of said Prospectus is March
26, 1997.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 1 - Underwriting agreement dated March 26, 1997.
Exhibit 2 - Letter agreement dated March 4, 1997.
SIGNATURE.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: April 8, 1996 s/ Manfred Steinfeld
-----------------------------
Manfred Steinfeld
5
<PAGE>
SHELBY WILLIAMS INDUSTRIES, INC.
2,000,000 SHARES(1)
COMMON STOCK
(PAR VALUE $0.05 PER SHARE)
UNDERWRITING AGREEMENT
March 26, 1997
LAZARD FRERES & CO. LLC
INTERSTATE/JOHNSON LANE CORPORATION
As Representatives of the several Underwriters
c/o Lazard Freres & Co. LLC
30 Rockefeller Plaza
New York, New York 10020
Dear Sirs:
Shelby Williams Industries, Inc., a Delaware corporation (the "Company"),
and Mr. Manfred Steinfeld ("Mr. Steinfeld") and The Fern and Manfred Steinfeld
Charitable Remainder Trust (the "Trust" and, together with Mr. Steinfeld, the
"Selling Stockholders") hereby confirm their agreement with the several
underwriters named in Schedule 1 hereto (the "Underwriters"), for whom you have
been duly authorized to act as representatives (in such capacity, the
"Representatives"), as set forth below. If you are the only Underwriters, all
references herein to the Representatives shall be deemed to be to the
Underwriters.
1. SHARES. Subject to the terms and conditions herein contained, the
Company proposes to sell to the several underwriters an aggregate of 569,000
shares held by the Company in treasury (the "Company Firm Shares") of the
Company's common stock, par value $0.05 per share ("Common Stock"), and the
Selling Stockholders propose to sell to the several underwriters an aggregate of
1,431,000 shares of Common Stock (the "Selling Stockholder Firm Shares") in the
respective amounts set forth in Schedule 2 hereto. The Company Firm Shares and
the Selling Stockholder Firm Shares are collectively referred to herein as the
"Firm Shares".
Each of the Company and Mr. Steinfeld agrees to sell to the several
Underwriters not more than 150,000 additional shares of Common Stock, or an
aggregate of 300,000 additional shares (any and all such shares referred to
herein as the "Option Shares"), if requested by the Representatives as provided
in Section 4 of this Agreement. The Firm Shares and any Option Shares are
collectively referred to herein as the "Shares."
2. REPRESENTATIONS AND WARRANTIES. Each of the Company and the Selling
Stockholders hereby represents and warrants to, and agrees with, each of the
several Underwriters that:
(a) A registration statement on Form S-3 (File No. 33-22741) with
respect to the Shares, including a prospectus subject to completion, has
been filed by the Company with the Securities and Exchange Commission (the
"Commission") under the Securities Act of 1933, as amended (the "Act"), and
one or more amendments to such registration statement may have been so
filed. After the execution of this Agreement, the Company will file with the
Commission either (i) if such registration statement, as it may have been
amended, has been declared by the Commission to be effective under the Act,
either (A) if the Company relies on Rule 434 under the Act, a Term Sheet (as
hereinafter defined) relating to the Shares, that shall identify the
Preliminary Prospectus (as hereinafter defined) that it supplements
containing such
- ---------
(1)Plus an option to purchase from each of Shelby Williams Industries, Inc. and
Manfred Steinfeld up to 150,000 additional shares, or an aggregate of 300,000
additional shares, to cover over-allotments.
<PAGE>
information as is required or permitted by Rule 434, 430A and 424(b) under
the Act or (B) if the Company does not rely on Rule 434 under the Act, a
prospectus in the form most recently included in an amendment to such
registration statement (or, if no such amendment shall have been filed, in
such registration statement), with such changes or insertions as are
required by Rule 430A under the Act or permitted by Rule 424(b) under the
Act, and in the case of either clause (i)(A) or (i)(B) of this sentence, as
have been provided to and approved by the Representatives prior to the
execution of this Agreement, or (ii) if such registration statement, as it
may have been amended, has not been declared by the Commission to be
effective under the Act, an amendment to such registration statement,
including a form of prospectus, a copy of which amendment has been furnished
to and approved by the Representatives prior to the execution of this
Agreement. No stop order suspending the effectiveness of such registration
statement has been issued and no proceeding for that purpose has been
initiated or threatened by the Commission. As used in this Agreement, the
term "Registration Statement" means such registration statement, as amended
at the time when it was or is declared effective (including any registration
statement for the same offering that becomes effective upon filing pursuant
to Rule 462(b) under the Act), including (i) all financial schedules and
exhibits thereto, (ii) all documents (or portions thereof) incorporated by
reference therein, and (iii) the information contained in the form of final
prospectus filed with the Commission pursuant to Rule 424(b) under the Act
in accordance with Section 5(a) hereof and deemed by virtue of Rule 430A
under the Act to be part of the registration statement at the time it was
declared effective; the term "Preliminary Prospectus" means each prospectus
subject to completion filed with such registration statement or any
amendment thereto (including the prospectus subject to completion, if any,
included in the Registration Statement or any amendment thereto at the time
it was or is declared effective and all documents (or portions thereof)
incorporated by reference therein) or filed with the Commission pursuant to
Rule 424(a) of the rules and regulations of the Commission under the Act;
the term "Prospectus" means (A) if the Company relies on Rule 434 under the
Act, the Term Sheet relating to the Shares that is first filed pursuant to
Rule 424(b)(7) under the Act, together with the Preliminary Prospectus
identified therein that such Term Sheet supplements; (B) if the Company does
not rely on Rule 434 under the Act, the prospectus first filed with the
Commission pursuant to Rule 424(b) under the Act; or (C) if the Company does
not rely on Rule 434 under the Act and if no prospectus is required to be
filed pursuant to Rule 424(b) under the Act, the prospectus included in the
Registration Statement and the term "Term Sheet" means any term sheet that
satisfies the requirements of Rule 434 under the Act. Any reference to the
"date" of a Prospectus that includes a Term Sheet shall mean the date of
such Term Sheet. Any reference herein to any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form S-3 under the
Act, as of the date of such Preliminary Prospectus or Prospectus, as the
case may be; any reference to any amendment or supplement to any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include any
documents filed after the date of such Preliminary Prospectus or Prospectus,
as the case may be, under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), and incorporated by reference in such Preliminary
Prospectus or Prospectus, as the case may be; and any reference to any
amendment to the Registration Statement shall be deemed to refer to and
include any annual report of the Company filed pursuant to Section 13(a) or
15(d) of the Exchange Act after the effective date of the Registration
Statement that is incorporated by reference in the Registration Statement;
(b) The Commission has not issued any order preventing or suspending the
use of any Preliminary Prospectus. When any Preliminary Prospectus was filed
with the Commission it complied in all material respects with the
requirements of, the Act and the rules and regulations of the Commission
thereunder and did not include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not
misleading. When the Registration Statement or any amendment thereto was or
is declared effective, it complied or will comply in all material respects
with the requirements of, the Act and the rules and regulations of the
Commission thereunder and did not or will not include any untrue statement
of a material fact or omit to state any material fact necessary to make the
statements therein not misleading.
2
<PAGE>
When the Prospectus or any amendment or supplement thereto is filed with the
Commission pursuant to Rule 424(b) (or, if the Prospectus or such amendment
or supplement is not required to be so filed, when the Registration
Statement or the amendment thereto containing such amendment or supplement
to the Prospectus was or is declared effective) and on the Firm Closing Date
and any Option Closing Date (both as hereinafter defined), the Prospectus,
as amended or supplemented at any such time, complied or will comply in all
material respects with the requirements of, the Act and the rules and
regulations of the Commission thereunder and did not or will not include any
untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The foregoing
provisions of this paragraph (b) do not apply to statements or omissions
made in any Preliminary Prospectus, the Registration Statement or any
amendment thereto or the Prospectus or any amendment or supplement thereto
in reliance upon and in conformity with information furnished to the Company
in writing by an Underwriter through the Representatives specifically for
inclusion therein;
(c) Each of the reports and registration statements filed or to be filed
by the Company with the Commission under the Act or the Exchange Act and
which are or will be incorporated by reference into any Preliminary
Prospects, the Prospectus or the Registration Statement, when they became or
become effective or were or are filed with the Commission, as the case may
be, conformed or will conform in all material respects to the requirements
of the Act or the Exchange Act, as the case may be, and the rules and
regulations of the Commission thereunder, and none of such documents
contained or will contain an untrue statement of a material fact or omitted
or will omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading;
(d) The only subsidiaries of the Company are Sellers & Josephson Inc., a
New Jersey corporation ("Sellers & Josephson") and Industrial Mueblera
Shelby Williams, S.A. de C.V., a corporation organized under the laws of the
United Mexican States ("IMSW"); neither Sellers & Josephson nor IMSW
individually would constitute a "significant subsidiary" within the meaning
of Rule 1-02(w) of Regulation S-X of the rules and regulations of the
Commission;
(e) The Company and each of its subsidiaries have been duly organized
and are validly existing as corporations in good standing under the laws of
their respective jurisdictions of incorporation and are duly qualified to
transact business as foreign corporations and are in good standing under the
laws of all other jurisdictions where the ownership or leasing of their
respective properties or the conduct of their respective businesses requires
such qualification, except to the extent that the failure to be so qualified
would not have a Material Adverse Effect. For purposes hereof, "Material
Adverse Effect" shall mean any effect that would, individually or in the
aggregate, have a material adverse effect on the condition, financial or
otherwise, results of operations, business or prospects of the Company and
its subsidiaries, taken as a whole;
(f) The Company and each of its subsidiaries has full power (corporate
and other) to own or lease their respective properties and conduct their
respective businesses as described in the Registration Statement and the
Prospectus or, if the Prospectus is not in existence, the most recent
Preliminary Prospectus; and the Company has full power (corporate and other)
to enter into this Agreement and to carry out all the terms and provisions
hereof to be carried out by it;
(g) The issued shares of capital stock of each of the Company's
subsidiaries have been duly authorized and validly issued, are fully paid
and non-assessable and are owned by the Company free and clear of any
security interests, liens, encumbrances, equities or claims ("Liens"), and
no other person has any option, warrant, call or other right to additional
capital stock of any subsidiary from such subsidiary of the Company, and
there are no outstanding securities or obligations that are convertible into
or exchangeable for capital stock of any subsidiary;
(h) The Company has an authorized, issued and outstanding capitalization
as set forth in the Prospectus or, if the Prospectus is not in existence,
the most recent Preliminary Prospectus. All of the
3
<PAGE>
issued shares of capital stock of the Company have been duly authorized and
validly issued and are fully paid and non-assessable. The Firm Shares and
the Option Shares have been duly authorized and validly issued and are fully
paid and non-assessable. No holders of outstanding shares of capital stock
of the Company are entitled as such to any preemptive or other rights to
subscribe for any of the Shares, and no holder of securities of the Company
has any right which has not been fully exercised or waived to require the
Company to register the offer or sale of any securities owned by such holder
under the Act in the public offering contemplated by this Agreement;
(i) The capital stock of the Company conforms to the description
thereof incorporated by reference in the Prospectus or, if the Prospectus is
not in existence, the most recent Preliminary Prospectus;
(j) The consolidated financial statements and schedules of the Company
and its consolidated subsidiaries, included or incorporated by reference in
the Registration Statement and the Prospectus (or, if the Prospectus is not
in existence, the most recent Preliminary Prospectus) fairly present the
financial position of the Company and its consolidated subsidiaries and the
results of operations and changes in financial condition as of the dates and
periods therein specified. Such financial statements and schedules have been
prepared in accordance with generally accepted accounting principles
consistently applied throughout the periods involved (except as otherwise
noted therein). The selected financial information set forth under the
caption "Selected Financial Information" in the Prospectus (or, if the
Prospectus is not in existence, the most recent Preliminary Prospectus)
fairly present, on the basis stated in the Prospectus (or such Preliminary
Prospectus), the information included therein;
(k) Ernst & Young LLP, which has certified certain financial statements
of the Company and its consolidated subsidiaries and which delivered its
report with respect to certain of the audited consolidated financial
statements and schedules included or incorporated by reference in the
Registration Statement and the Prospectus (or, if the Prospectus is not in
existence, the most recent Preliminary Prospectus), are independent public
accountants as required by the Act, the Exchange Act and the respective
rules and regulations thereunder;
(l) This Agreement has been duly authorized, executed and delivered by
the Company;
(m) No legal or governmental proceedings are pending to which the
Company or any of its subsidiaries is a party or to which the property of
the Company or any of its subsidiaries is subject that are required to be
described in the Registration Statement or the Prospectus and are not
described therein (or, if the Prospectus is not in existence, the most
recent Preliminary Prospectus), and to the knowledge of the Company no such
proceedings have been threatened against the Company or any of its
subsidiaries or with respect to any of their respective properties; and the
Company and each subsidiary have conducted their respective businesses so as
to comply in all material respects with all applicable statutes, ordinances,
rules, regulations and orders of any governmental authority; and no contract
or other document is required to be described in the Registration Statement
or the Prospectus or to be filed as an exhibit to the Registration Statement
that is not described therein (or, if the Prospectus is not in existence,
the most recent Preliminary Prospectus) or filed as required; and each such
contract or other document is valid and binding on the Company or a
subsidiary of the Company, as the case may be, and the other parties thereto
and is in full force and effect;
(n) The offering and sale of the Company Firm Shares and Option Shares
to the Underwriters by the Company pursuant to this Agreement, the
compliance by the Company with the other provisions of this Agreement and
the consummation of the other transactions herein contemplated do not (i)
require the consent, approval, authorization, registration or qualification
of or with any governmental authority, except such as have been obtained,
such as may be required under state securities or blue sky laws and, if the
registration statement filed with respect to the Shares (as amended) is not
effective under the Act as of the time of execution hereof, such as may be
required (and shall be obtained as provided in this Agreement) under the
Act, (ii) materially conflict with or result in a material breach or
violation of any of the terms and provisions of, or constitute a material
default under, any indenture, mortgage, deed of trust,
4
<PAGE>
lease or other agreement or instrument to which the Company or any of its
subsidiaries is a party or by which the Company or any of its subsidiaries
or any of their respective properties are bound, or the charter documents or
by-laws of the Company or any of its subsidiaries, or any statute or any
judgment, decree, order, rule or regulation of any court or other
governmental authority or any arbitrator applicable to the Company or any of
its subsidiaries, or (iii) require the consent of the shareholders of the
Company;
(o) Neither the Company nor any of its officers, directors or affiliates
has, directly or indirectly, (i) taken any action designed to cause or to
result in, or that has constituted or which might reasonably be expected to
constitute, the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Shares or (ii) except
for the sale by the Company of the Company Firm Shares and the Option Shares
hereby, since the filing of the Registration Statement (A) sold, bid for,
purchased, or paid anyone any compensation for soliciting purchases of, the
Shares or (B) paid or agreed to pay to any person any compensation for
soliciting another to purchase any other securities of the Company in each
case, which may reasonably be expected to constitute the stabilization or
manipulation of the price of any security of the Company to facilitate the
sale or resale of the Shares;
(p) Subsequent to the respective dates as of which information is given
in the Registration Statement and the Prospectus (or, if the Prospectus is
not in existence, the most recent Preliminary Prospectus), (i) the Company
and its subsidiaries have not incurred any liability or obligation, direct
or contingent, nor entered into any transaction not in the ordinary course
of business, in either case which is material to the Company and its
subsidiaries taken as a whole; (ii) the Company has not purchased any of its
outstanding capital stock, nor declared, paid or otherwise made any dividend
or distribution of any kind on its capital stock other than in accordance
with ordinary past practice; (iii) there has not been any material change in
the capital stock, short-term debt or long-term debt of the Company and its
consolidated subsidiaries, except in each case as described in or
contemplated by the Prospectus (or, if the Prospectus is not in existence,
the most recent Preliminary Prospectus) and (iv) neither the Company nor any
of its subsidiaries has sustained any material loss or interference with
their respective businesses or properties from fire, flood, hurricane,
accident or other calamity, whether or not covered by insurance, or from any
labor dispute or any legal or governmental proceeding, and there has not
been any material adverse change, or any development involving a prospective
material adverse change, in or affecting the condition (financial or
otherwise), earnings, business or prospects of the Company and its
subsidiaries taken as a whole, except in each case as described in the
Prospectus (exclusive of any amendment or supplement thereto);
(q) The Company and each of its subsidiaries have good and marketable
title to all items of real property and marketable title to all personal
property owned by each of them, in each case free and clear of any security
interests, liens, encumbrances, equities, claims and other defects, except
for liens for taxes not yet due and payable and any other encumbrances such
as do not materially and adversely affect the value of such property and do
not interfere with the use made or proposed to be made of such property by
the Company or such subsidiary, in each case except as described in or
contemplated by the Prospectus (or, if the Prospectus is not in existence,
the most recent Preliminary Prospectus);
(r) No labor dispute with the employees of the Company or any of its
subsidiaries exists or to the knowledge of the Company is threatened or
imminent that could result in a material adverse change in the condition,
financial or otherwise, results of operations, business or prospects of the
Company and its subsidiaries taken as a whole, except as described in the
Prospectus (or, if the Prospectus is not in existence, the most recent
Preliminary Prospectus);
(s) The Company and its subsidiaries own or possess, or can acquire on
reasonable terms, all material patents, patent applications, trademarks,
service marks, trade names, licenses, copyrights and proprietary or other
confidential information currently employed by them in connection with their
respective businesses, and neither the Company nor any such subsidiary has
received any written notice of infringement of or conflict with asserted
rights of any third party with respect to any of the foregoing which, singly
or in the aggregate, if the subject of an unfavorable decision, ruling or
finding, would result in a
5
<PAGE>
material adverse change in the condition, financial or otherwise, results of
operations, business or prospects of the Company and its subsidiaries taken
as a whole, except as described in the Prospectus (or, if the Prospectus is
not in existence, the most recent Preliminary Prospectus);
(t) The Company has not distributed and, prior to the later of (i) the
Firm Closing Date and (ii) the completion of the distribution of the Shares,
will not distribute any offering material in connection with the offering
and sale of the Shares other than the Registration Statement or any
amendment thereto, any Preliminary Prospectus or the Prospectus or any
amendment or supplement thereto, or other materials, if any, permitted by
the Act;
(u) The conditions for use of a Registration Statement on Form S-3 set
forth in the General Instructions to Form S-3 have been satisfied with
respect to the Company and the transactions contemplated by this Agreement
and the Registration Statement; and
(v) The Shares are, and at the Firm Closing Date and the Option Closing
Date, as the case may be duly, will be, listed for trading on the New York
Stock Exchange, Inc. (the "NYSE").
3. REPRESENTATIONS AND WARRANTIES OF THE SELLING STOCKHOLDERS. The Selling
Stockholders, jointly and severally, represents and warrants to, and agrees
with, each of the several Underwriters that:
(a) this Agreement has been duly executed and delivered by or on behalf
of the Selling Stockholders; the performance of this Agreement by the Trust
and the consummation by the Trust of the transactions herein contemplated
are authorized under the terms of the agreement governing the trust (the
"Trust Agreement"); and the performance of this Agreement by the Selling
Stockholders and the consummation by the Selling Stockholders of the
transactions herein contemplated will not conflict with or result in a
breach or violation of any terms or provisions of, or constitute a default
under, in the case of the Trust, the Trust Agreement, and in the case of
both Selling Stockholders any indenture, mortgage, deed of trust, loan
agreement or other agreement or instrument known to such counsel to which
any Selling Stockholder is bound, or to which any of its property or assets
is subject, nor will such action result in any violation of the provisions
of any statute or order, rule or regulation of any court or governmental
agency or body having jurisdiction over any Selling Stockholder or the
property of any Selling Stockholder;
(b) the Trust has been duly organized and is validly existing as a trust
under the laws of its jurisdiction of organization; Manfred Steinfeld and
Fern Steinfeld are on the date hereof and, unless notice on the Firm Closing
Date or the Option Closing Date, will be the sole Trustees of the Trust;
(c) on the date hereof the Selling Stockholders have, and immediately
prior to the Firm Closing Date or the Option Closing Date, as the case may
be, the Selling Stockholders will have good and valid title to the Shares to
be sold at such Closing Date by such Selling Stockholders under this
Agreement, free and clear of all liens, encumbrances, equities or claims,
and full right, power and authority to sell, assign, transfer and deliver
the Shares to be sold by such Selling Stockholders hereunder;
(d) the delivery by the Selling Stockholders to the several Underwriters
of certificates for the Shares being sold hereunder by the Selling
Stockholders against payment therefor as provided herein, will convey good
and marketable title to such Shares to the several Underwriters, free and
clear of all security interests, liens, encumbrances, equities, claims or
other defects;
(e) the sale of Selling Stockholder Firm Shares by such Selling
Stockholder pursuant hereto is not prompted by any adverse information
concerning the Company that is not set forth in the Registration Statement
or the Prospectus (or, if the Prospectus is not in existence, the most
recent Preliminary Prospectus);
(f) the sale of Selling Stockholder Firm Shares to the Underwriters by
such Selling Stockholder pursuant to this Agreement, the compliance by such
Selling Stockholder with the other provisions of this Agreement and the
consummation of the other transactions herein contemplated do not (i)
require the
6
<PAGE>
consent, approval, authorization, registration or qualification of or with
any governmental authority, except such as have been obtained, such as may
be required under the state securities or blue sky laws and, if the
Registration Statement filed with respect to the Selling Stockholder Firm
Shares (as amended) is not effective under the Act as of the time of
execution hereof, such as may be required (and shall be obtained as provided
in this Agreement) under the Act, or (ii) conflict with or result in a
material breach or violation of any of the terms and provisions of, or
constitute a material default under, any indenture, mortgage, deed of trust,
lease or other agreement or instrument to which such Selling Stockholder is
a party or by which such Selling Stockholder or any of their respective
properties are bound, or, in the case of the Trust, the Trust Agreement
establishing the Trust or any statute or any judgment, decree, order, rule
or regulation of any court or other governmental authority or any
arbitrator, applicable to such Selling Stockholder;
(g) based on a review of the Registration Statement and a due and
diligent inquiry regarding the Company, nothing came to the attention of
such Selling Stockholder that caused such Selling Stockholder to believe
that (i) when the Registration Statement or any amendment thereto was or is
declared effective, it included or will include any untrue statement of a
material fact or omitted or will omit to state any material fact necessary
to make the statements therein not misleading; or (ii) when the Prospectus
or any amendment or supplement thereto is filed with the Commission pursuant
to Rule 424(b) (or, if the Prospectus or such amendment or supplement is not
required to be so filed, when the Registration Statement or the amendment
thereto containing such amendment or supplement to the Prospectus was or is
declared effective), on the date when the Prospectus is otherwise amended or
supplemented and on the Firm Closing Date, the Prospectus, as amended or
supplemented at any such time, included or will include any untrue statement
of a material fact or omitted or will omit to state any material fact
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The foregoing
provisions of this paragraph (g) do not apply to statements or omissions
made in the Registration Statement or any amendment thereto or the
Prospectus or any amendment or supplement thereto in reliance upon and in
conformity with information furnished in writing to the Company by an
Underwriter through the Representatives specifically for inclusion therein;
(h) The Selling Stockholders have not distributed and, prior to the
later of (i) the Firm Closing Date and (ii) the completion of the
distribution of the Shares, will not distribute any offering material in
connection with the offering and sale of the Shares other than the
Registration Statement or any amendment thereto, any Preliminary Prospectus
or the Prospectus or any amendment or supplement thereto, or other
materials, if any, permitted by the Act;
(i) The information under the caption "Selling Stockholders" in the
Prospectus (or if the Prospectus is not in existence, the most recent
Preliminary Prospectus) is true and accurate; and
(j) In order to document the Underwriters' compliance with the
reporting and withholding provisions of the Tax Equity and Fiscal
Responsibility Act of 1982 with respect to the transactions herein
contemplated, such Selling Stockholder will deliver to you prior to or at
the Firm Closing Date a properly completed and executed United States
Treasury Department Form W-9, or other applicable form or statement
specified by the Treasury Department regulations in lieu thereof.
4. PURCHASE, SALE AND DELIVERY OF THE SHARES. (a) On the basis of the
representations, warranties, agreements and covenants herein contained and
subject to the terms and conditions herein set forth, the Company and the
Selling Stockholders agree to sell to each of the Underwriters, and each of the
Underwriters, severally and not jointly, agrees to purchase from the Company and
the Selling Stockholders, at a purchase price of $13.00 per share, the number of
Firm Shares set forth opposite the name of such Underwriter in Schedule 1
hereto. One or more certificates in definitive form for the Firm Shares that the
several Underwriters have agreed to purchase hereunder, and in such denomination
or denominations and registered in such name or names as the Representatives
request upon notice to the Company at least 48 hours prior to the Firm Closing
Date, shall be delivered by or on behalf of the Company to the Representatives
for the respective accounts of
7
<PAGE>
the Underwriters, against payment by or on behalf of the Underwriters of the
purchase price therefor at the election of the Company and the Selling
Stockholders by (i) wire transfer or (ii) certified or official bank check or
checks drawn upon or by a New York Clearing House bank and payable in next-day
funds, made to the order of the Company and the Selling Stockholders. Such
delivery of and payment for the Firm Shares shall be made at the offices of
Mayer, Brown & Platt, 190 South LaSalle Street, Chicago, Illinois 60606 at 9:30
A.M., Chicago time, on April 2, 1997, or at such other place, time or date as
the Representatives, the Company and the Selling Stockholders may agree upon or
as the Representatives may determine pursuant to Section 11 hereof, such time
and date of delivery against payment being herein referred to as the "Firm
Closing Date". The Company and the Selling Stockholders will make such
certificate or certificates for the Firm Shares available for checking and
packaging by the Representatives at the offices of Lazard Freres & Co. LLC, New
York, New York, or through the facilities of The Depository Trust Company at
least 24 hours prior to the Firm Closing Date.
(b) For the purpose of covering any over-allotments in connection with the
distribution and sale of the Firm Shares as contemplated by the Prospectus, the
Company and Mr. Steinfeld hereby grant to the several Underwriters an option to
purchase, severally and not jointly, the Option Shares. The purchase price to be
paid for any Option Shares shall be the same price per share as the price per
share for the Firm Shares set forth above in paragraph (a) of this Section 4.
The option granted hereby may be exercised as to all or any part of the Option
Shares from time to time within thirty days after the date of the Prospectus
(or, if such thirtieth day shall be a Saturday or Sunday or a holiday, on the
next business day thereafter when the NYSE is open for trading). The
Underwriters shall not be under any obligation to purchase any of the Option
Shares prior to the exercise of such option. The Representatives may from time
to time exercise the option granted hereby by giving notice in writing or by
telephone (confirmed in writing) to the Company setting forth the aggregate
number of Option Shares as to which the several Underwriters are then exercising
the option and the date and time for delivery of and payment for such Option
Shares. Any such date of delivery shall be determined by the Representatives but
shall not be earlier than two business days or later than five business days
after such exercise of the option and, in any event, shall not be earlier than
the Firm Closing Date. The time and date set forth in such notice, or such other
time on such other date as the Representatives and the Company may agree upon or
as the Representatives may determine pursuant to Section 11 hereof, is herein
called the "Option Closing Date" with respect to such Option Shares. Each of the
Firm Closing Date and the Option Closing Date is herein called a "Closing Date."
Upon exercise of the option as provided herein, the Company and Mr. Steinfeld
shall become obligated to sell, on a pro rata basis, to each of the several
Underwriters, and, subject to the terms and conditions herein set forth, each of
the Underwriters (severally and not jointly) shall become obligated to purchase
from the Company, the same percentage of the total number of the Option Shares
as to which the several Underwriters are then exercising the option as such
Underwriter is obligated to purchase of the aggregate number of Firm Shares, as
adjusted by the Representatives in such manner as it deems advisable to avoid
fractional shares. If the option is exercised as to all or any portion of the
Option Shares, one or more certificates in definitive form for such Option
Shares, and payment therefor, shall be delivered on the related Option Closing
Date in the manner, and upon the terms and conditions, set forth in paragraph
(a) of this Section 4, except that reference therein to the Firm Shares and the
Firm Closing Date shall be deemed, for purposes of this paragraph (b), to refer
to such Option Shares and Option Closing Date, respectively.
(c) It is understood that you, individually and not as the Representatives,
may (but shall not be obligated to) make payment on behalf of any Underwriter or
Underwriters for any of the Shares to be purchased by such Underwriter or
Underwriters. No such payment shall relieve such Underwriter or Underwriters
from any of its or their obligations hereunder.
5. OFFERING BY THE UNDERWRITERS. After the Registration Statement becomes
effective, the several Underwriters will offer the Shares for sale to the public
on the terms and conditions set forth in the Prospectus.
6. COVENANTS OF THE COMPANY. The Company covenants and agrees with each of
the Underwriters that:
(a) The Company will use its best efforts to cause the Registration
Statement, if not effective at the time of execution of this Agreement, and
any amendments thereto to become effective as promptly as
8
<PAGE>
possible. If required, the Company will file the Prospectus or any Term
Sheet that constitutes a part thereof and any amendment or supplement
thereto with the Commission in the manner and within the time period
required by Rules 434 and 424(b) under the Act. During any time when a
prospectus relating to the Shares is required to be delivered under the Act,
the Company will (i) comply with all requirements imposed upon it by the Act
and the rules and regulations of the Commission thereunder to the extent
necessary to permit the continuance of sales of or dealings in the Shares in
accordance with the provisions hereof and of the Prospectus, as then amended
or supplemented, and (ii) not file with the Commission the Prospectus or the
amendment referred to in the second sentence of Section 2(a) hereof, any
amendment or supplement to such Prospectus or any amendment to the
Registration Statement (in any case, including by the filing of any document
which would be incorporated by reference into the Prospectus or Registration
Statement, as the case may be) of which the Representatives shall not
previously have been advised and furnished with a copy for a reasonable
period of time prior to the proposed filing and as to which filing the
Representatives shall not have given their consent. The Company will prepare
and file with the Commission, in accordance with the rules and regulations
of the Commission, promptly upon request by the Representatives or counsel
for the Underwriters, any amendments to the Registration Statement or
amendments or supplements to the Prospectus that may be necessary or
advisable in connection with the distribution of the Shares by the several
Underwriters, and will use its best efforts to cause any such amendment to
the Registration Statement to be declared effective by the Commission as
promptly as possible. The Company will advise the Representatives, promptly
after receiving notice thereof, of the time when the Registration Statement
or any amendment thereto has been filed or declared effective or the
Prospectus or any amendment or supplement thereto has been filed and will
provide evidence satisfactory to the Representatives of each such filing or
effectiveness. The Company will file promptly all reports and any definitive
proxy or information statements required to be filed by the Company with the
Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act
subsequent to the date of the Prospectus and for so long as the delivery of
a prospectus is required in connection with the offering, sale and
distribution of the Shares;
(b) The Company will advise the Representatives, promptly after
receiving notice or obtaining knowledge thereof, of (i) the issuance by the
Commission of any stop order suspending the effectiveness of the
Registration Statement or any amendment thereto or any order preventing or
suspending the use of any Preliminary Prospectus or the Prospectus or any
amendment or supplement thereto, (ii) the suspension of the qualification of
the Shares for offering or sale in any jurisdiction, (iii) the institution,
threatening or contemplation of any proceeding for any such purpose or (iv)
any request made by the Commission for amending the Registration Statement,
for amending or supplementing the Prospectus or for additional information.
The Company will use its best efforts to prevent the issuance of any such
stop order and, if any such stop order is issued, to obtain the withdrawal
thereof as promptly as possible;
(c) The Company will arrange for the qualification of the Shares for
offering and sale under the securities or blue sky laws of such
jurisdictions as the Representatives may designate and will continue such
qualifications in effect for as long as may be necessary to complete the
distribution of the Shares, provided, however, that in connection therewith
the Company shall not be required to qualify as a foreign corporation or to
execute a general consent to service of process in any jurisdiction;
(d) If, at any time prior to the later of (i) the final date when a
prospectus relating to the Shares is required to be delivered under the Act
or (ii) the Option Closing Date, any event occurs as a result of which the
Prospectus, as then amended or supplemented, would include any untrue
statement of a material fact or omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, or if for any other reason it is
necessary at any time to amend or supplement the Prospectus or to file under
the Exchange Act any document which would be incorporated by reference in
the Prospectus to comply with the Act, the Exchange Act or the respective
rules or regulations of the Commission thereunder, the Company will promptly
notify the Representatives thereof and, subject to Section 6(a) hereof, will
prepare and file with the Commission, at
9
<PAGE>
the Company's expense, an amendment to the Registration Statement or an
amendment or supplement to the Prospectus or any such incorporated document
that corrects such statement or omission or effects such compliance;
(e) The Company will, without charge, provide (i) to the Representatives
and to counsel for the Underwriters a signed copy of the registration
statement originally filed with respect to the Shares and each amendment
thereto (in each case including exhibits thereto) and all documents or
information incorporated by reference therein, (ii) to each other
Underwriter, a conformed copy of such registration statement and each
amendment thereto (in each case without exhibits thereto), but including all
documents or information incorporated by reference therein and (iii) so long
as a prospectus relating to the Shares is required to be delivered under the
Act, as many copies of each Preliminary Prospectus or the Prospectus or any
amendment or supplement thereto as the Representatives may reasonably
request; without limiting the application of clause (iii) of this sentence,
the Company, not later than (A) 6:00 PM, New York City time, on the date of
determination of the public offering price, if such determination occurred
at or prior to 10:00 AM, New York City time, on such date or (B) 12:00 Noon,
New York City time, on the business day following the date of determination
of the public offering price, if such determination occurred after 10:00 AM,
New York City time, on such date, will deliver to the Underwriters, without
charge, as many copies of the Prospectus and any amendment or supplement
thereto as the Representatives may reasonably request for purposes of
confirming orders that are expected to settle on the Firm Closing Date;
(f) The Company will apply the net proceeds from the sale of the Shares
as set forth under "Use of Proceeds" in the Prospectus;
(g) The Company will not, directly or indirectly, without the prior
written consent of Lazard Freres & Co. LLC, on behalf of the Underwriters,
offer, sell, offer to sell, pledge, contract to sell, grant any option to
purchase or otherwise sell or dispose (or announce any offer, sale, offer of
sale, pledge, contract of sale, grant of any option to purchase or other
sale or disposition) of any shares of capital stock of the Company or any
securities convertible into, or exchangeable or exercisable for, shares of
capital stock of the Company for a period of 180 days after the date hereof,
except pursuant to this Agreement and except for sales of up to 350,000
shares of Common Stock issuable pursuant to the exercise of employee or
director stock options, which sales may be effected at any time after the
date hereof;
(h) Neither the Company nor any of its officers, directors or affiliates
will, directly or indirectly, (i) take any action designed to cause or to
result in, or that has constituted or which might reasonably be expected to
constitute, the stabilization or manipulation of the price of any security
of the Company to facilitate the sale or resale of the Shares or (ii)(A)
sell, bid for, purchase, or pay anyone any compensation for soliciting
purchases of, the Shares or (B) pay or agree to pay to any person any
compensation for soliciting another to purchase any other securities of the
Company, in each case which may reasonably be expected to constitute the
stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares;
(i) During the period of five years hereafter, the Company will furnish
to you and, upon request, to each of the other Underwriters, as soon as
practicable after the end of each fiscal year, a copy of its annual report
to stockholders for such year, and the Company will furnish to you (i) as
soon as available, a copy of each report or definitive proxy statement of
the Company filed with the Commission under the Exchange Act or mailed to
stockholders and (ii) from time to time, such other information concerning
the Company as you may reasonably request; and
(j) To make generally available to its securityholders as soon as
practicable, but in any event not later than eighteen months after the
effective date of the Registration Statement (as defined in Rule 158(c)), an
earning statement of the Company and its subsidiaries (which need not be
audited) complying with Section 11(a) of the Act and the rules and
regulations of the Commission thereunder (including, at the option of the
Company, Rule 158).
10
<PAGE>
7. COVENANTS OF THE SELLING STOCKHOLDERS. The Selling Stockholders
covenant and agree with each of the Underwriters that:
(a) No Selling Stockholder will, directly or indirectly, without the
prior written consent of Lazard Freres & Co. LLC, on behalf of the
Underwriters, offer, sell, offer to sell, pledge, contract to sell, grant
any option to purchase or otherwise sell or dispose (or announce any offer,
sale, offer of sale, contract of sale, grant of any option to purchase or
other sale or disposition) of any capital stock of the Company legally or
beneficially owned by such Selling Stockholder or any securities convertible
into or exchangeable or exercisable for, capital stock of the Company for a
period of 180 days after the date hereof; and
(b) No Selling Stockholder will, directly or indirectly, (i) take any
action designed to cause or to result In, or that has constituted or which
might reasonably be expected to constitute, the stabilization or
manipulation of the price of any security of the Company to facilitate the
sale or resale of the Shares or (ii)(A) sell, bid for, purchase, attempt to
induce any person to purchase, or pay anyone any compensation for soliciting
purchases of the Shares or (B) pay or agree to pay to any person any
compensation for soliciting another to purchase any other securities of the
Company, in each case which may reasonably be expected to constitute the
stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares.
8. EXPENSES. The Company and the Selling Stockholders covenant and agree
with one another and with the several Underwriters that the Company and the
Selling Stockholders will pay or cause to be paid, on a pro rate basis based on
the number of Shares to be sold by the Company, on the one hand, and the Selling
Stockholders, on the other, all costs and expenses incident to the performance
of its obligations under this Agreement, whether or not the transactions
contemplated herein are consummated or this Agreement is terminated pursuant to
Section 13 hereof, including all costs and expenses incident to (i) the printing
or other production of documents with respect to the transactions, including any
costs of printing the registration statement originally filed with respect to
the Shares and any amendment thereto, any Preliminary Prospectus and the
Prospectus and any amendment or supplement thereto, this Agreement and any blue
sky memoranda, (ii) all arrangements relating to the delivery to the
Underwriters of copies of the foregoing documents, (iii) the fees and
disbursements of the counsel, the accountants and any other experts or advisors
retained by the Company and/or the Selling Stockholders, (iv) preparation,
issuance and delivery to the Underwriters of any certificates evidencing the
Shares, including transfer agent's and registrar's fees, (v) the qualification
of the Shares under state securities and blue sky laws, including filing fees
and fees and disbursements of counsel for the Underwriters relating thereto, but
not in excess of $10,000, (vi) the filing fees of the Commission and the filing
fees incident to securing any required review by the National Association of
Securities Dealers, Inc. of the terms of the sale of the Shares, (vii) any
listing of the Shares on the NYSE and (viii) any meetings with prospective
investors in the Shares other than as shall have been specifically approved by
the Representatives to be paid for by the Underwriters). If the sale of the
Shares provided for herein is not consummated because any condition to the
obligations of the Underwriters set forth in Section 9 hereof is not satisfied,
because this Agreement is terminated pursuant to Section 13 hereof or because of
any failure, refusal or inability on the part of the Company or the Selling
Stockholders to perform all of their obligations and satisfy all conditions on
their parts to be performed or satisfied hereunder other than by reason of a
default by any of the Underwriters, the Company will reimburse the Underwriters
severally upon demand for all reasonable out-of-pocket expenses against
presentation of invoices (including counsel fees and disbursements) that shall
have been incurred by them in connection with the proposed purchase and sale of
the Shares.
9. CONDITIONS OF THE UNDERWRITERS' OBLIGATIONS. The obligations of the
several Underwriters to purchase and pay for the Shares to be delivered at each
Closing Date shall be subject, in the Representatives' sole discretion, to the
accuracy of the representations and warranties of the Company and the Selling
Stockholders contained herein as of the date hereof and as of such Closing Date,
as if made on and as of such Closing Date, to the accuracy of the statements of
the Company's officers made in any certificates pursuant to the provisions
11
<PAGE>
hereof, to the performance by the Company and the Selling Stockholders of their
covenants and agreements hereunder and to the following additional conditions:
(a) If the Registration Statement or any amendment thereto filed prior
to the Firm Closing Date has not been declared effective as of the time of
execution hereof, the Registration Statement or such amendment shall have
been declared effective not later than 11 A.M., New York time, on the date
on which the amendment to the registration statement originally filed with
respect to the Shares or to the Registration Statement, as the case may be,
containing information regarding the public offering price of the Shares has
been filed with the Commission, or such later time and date as shall have
been consented to by the Representatives; if required, the Prospectus and
any amendment or supplement thereto shall have been filed with the
Commission in the manner and within the time period required by Rule 424(b)
under the Act; no stop order suspending the effectiveness of the
Registration Statement or any amendment thereto shall have been issued, and
no proceedings for that purpose shall have been instituted or threatened or,
to the knowledge of the Company or the Representatives, shall be
contemplated by the Commission, and the Company shall have complied with any
request of the Commission for additional information (to be included in the
Registration Statement or the Prospectus or otherwise) to your reasonable
satisfaction.
(b) You shall not have advised the Company that the Registration
Statement or Prospectus, or any amendment or supplement thereto, contains
any untrue statement of fact or omits to state any fact which, you have
concluded, is material and in the case of an omission is required to be
stated therein or is necessary to make the statements therein not
misleading.
(c) The Representatives shall have received an opinion, dated such
Closing Date, of D'Ancona & Pflaum, counsel for the Company, to the effect
that:
(i) the Company been duly organized and is validly existing as a
corporation in good standing under the laws of the State of Delaware with
the power (corporate and other) and authority to own or lease its
properties and conduct its business as described in the Registration
Statement and the Prospectus; the Company has the power (corporate and
other) to enter into this Agreement and to carry out all the terms and
provisions hereof to be carried out by it, and the Company is duly
qualified to transact business as a foreign corporation and is in good
standing under the laws of the states identified in such opinion;
(ii) based solely upon a certificate of the Secretary of State of
the State of New Jersey, Sellers & Josephson is a validly existing
corporation in good standing under the laws of the State of New Jersey
with the power (corporate and other) and authority to own or lease its
properties and conduct its business as described in the Registration
Statement and the Prospectus, and Sellers & Josephson is duly qualified
to transact business as a foreign corporation and is in good standing
under the laws of the states identified in such opinion;
(iii) all of the issued and outstanding shares of capital stock of
each of the Company's subsidiaries has been duly authorized and validly
issued, are fully paid and non-assessable and is owned by the Company or
a subsidiary of the Company, as the case may be, free and clear of any
security interests, liens, encumbrances, equities or claims;
(iv) the Company has an authorized, issued and outstanding
capitalization as set forth in the Prospectus, all of the issued shares
of capital stock of the Company have been duly authorized and validly
issued and are fully paid and non assessable, have been issued in
compliance with all applicable federal and state securities laws and were
not issued in violation of or subject to any preemptive rights or other
rights to subscribe for or purchase securities; no holders of outstanding
shares of capital stock of the Company are entitled as such to any
preemptive or other rights to subscribe for any of the Shares; no holders
of securities of the Company are entitled to have such securities
registered under the Registration Statement, and the capital stock of the
Company conforms to the description thereof incorporated by reference in
the Prospectus;
12
<PAGE>
(v) all of the Firm Shares have been duly authorized and validly
issued and are fully paid and non-assessable, have been issued in
compliance with all applicable federal and state securities laws, were
not issued in violation of or subject to any preemptive rights or other
rights to subscribe for or purchase securities of which such counsel has
knowledge after due inquiry and are not subject to restrictions on
transfer; the Firm Shares have been duly listed for trading on the NYSE;
(vi) this Agreement has been duly authorized, executed and delivered
by the Company;
(vii) the Registration Statement is effective under the Act; any
required filing of the Prospectus pursuant to Rule 424(b) has been made
in the manner and within the time period required by Rule 424(b); and no
stop order suspending the effectiveness of the Registration Statement or
any amendment thereto has been issued, and no proceedings for that
purpose have been instituted or, to the best knowledge of such counsel,
are threatened or contemplated by the Commission;
(viii) the registration statement originally filed with respect to
the Shares and each amendment thereto and the Prospectus, and the
information incorporated therein by reference (in each case, other than
the financial statements and other financial information contained
therein, as to which such counsel need express no opinion) comply as to
form in all material respects with the applicable requirements of the
Act, the Exchange Act and the respective rules and regulations of the
Commission thereunder;
(ix) The documents incorporated by reference in the Prospectus or
any further amendment or supplement thereto made by the Company prior to
such Closing Date (other than the financial statements and related
schedules therein, as to which such counsel need express no opinion),
when they or any further amendment or supplement thereto made by the
Company prior to such Closing Date were filed with the Commission
complied as to form in all material respects with the requirements of the
Exchange Act and the rules and regulations of the Commission thereunder;
and they have no reason to believe that any of such documents, when such
documents were filed, contained an untrue statement of a material fact or
omitted to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they
were made when such documents were so filed, not misleading;
(x) no consent, approval, authorization, order, filing, registration
or qualification of or with any court or governmental authority or agency
is required for the issue and sale of the Shares or the consummation of
the transactions contemplated by this Agreement, except such as may be
required and have been obtained under the Act and the rules and
regulations of the Commission thereunder and such as may be required
under state securities or Blue Sky laws in connection with the
distribution of the Shares by the Underwriters; and, the issue and sale
of the Shares, the execution and delivery of this Agreement and the
consummation of the transactions contemplated herein will not conflict
with or constitute a breach of, or default under or result in the
creation or imposition of any Lien upon any property or assets the
Company or any of its subsidiaries pursuant to any contract, indenture,
mortgage, loan agreement, note, lease or other instrument, known to such
counsel, of which the Company or any of its subsidiaries is a party or by
which it or any of them may be bound or to which any of the property or
assets of the Company or any of its subsidiaries is subject, nor will
such action result in any violation of the provisions of the charter or
by-laws of the Company or any of its subsidiaries, or any law,
administrative regulation or administrative or court decree or order
applicable to the Company or any of its subsidiaries; and
(xi) To the best knowledge of such counsel (x) there are no legal or
governmental actions, suits or proceedings pending or threatened to which
the Company or any of its subsidiaries is a party or to which any of the
properties of the Company or any subsidiary is subject which, if decided
adversely, are reasonably likely, individually or in the aggregate, to
result in any Material Adverse Effect, or is reasonably likely to
adversely affect the offering of the Shares or that are required to be
described in the Registration Statement or the Prospectus and are not so
described and (y) there is no contract or
13
<PAGE>
other document that is required to be described in the Registration
Statement or the Prospectus or to be filed as an exhibit to the
Registration Statement that is not so described or filed as required.
Such counsel shall also state that no facts have come to their attention
which have caused them to believe that the Registration Statement or any
amendment thereto as of its effective date contained any untrue statement of
a material fact or omitted to state any material fact required to be stated
therein or necessary to make the statements therein not misleading, or that
the Prospectus, as of its date and as amended or supplemented at such
Closing Date, contained or contains any untrue statement of a material fact
or omitted or omits to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading
In rendering any such opinion, such counsel may rely, as to matters of
fact, to the extent such counsel deems proper, on certificates of
responsible officers of the Company and public officials.
References to the Registration Statement and the Prospectus in this
paragraph (c) shall include any amendment or supplement thereto at the date
of such opinion.
(d) You shall have received the opinion, dated such Closing Date, of
D'Ancona & Pflaum, counsel for the Selling Stockholders, to the effect that:
(i) this Agreement has been duly executed and delivered by or on
behalf of each of the Selling Stockholders; the performance of this
Agreement by the Trust and the consummation by the Trust of the
transactions herein contemplated are authorized under the terms of the
Trust Agreement; and the performance of this Agreement by the Selling
Stockholders and the consummation by the Selling Stockholders of the
transactions herein contemplated will not conflict with or result in a
breach or violation of any terms or provisions of, or constitute a
default under, in the case of the Trust, the Trust Agreement, and in the
case of both Selling Stockholders any indenture, mortgage, deed of trust,
loan agreement or other agreement or instrument known to such counsel to
which any Selling Stockholder is bound, or to which any of its property
or assets is subject, nor will such action result in any violation of the
provisions of any statute or order, rule or regulation, known to such
counsel, of any court or governmental agency or body having jurisdiction
over any Selling Stockholder or the property of any Selling Stockholder;
(ii) the Trust has been duly organized and is validly existing as a
trust under the laws of its jurisdiction of organization;
(iii) no consent, approval, authorization or order of, or filing
with, any court or governmental agency or bodies is required for the
consummation of the transactions contemplated by this Agreement in
connection with the sale of Shares to be sold by the Selling Stockholders
hereunder, except such as have been obtained under the Act and such as
may be required under state securities laws in connection with the
purchase and distribution of such Shares by the Underwriters;
(iv) the Selling Stockholders are the record owners of the Shares to
be sold by them hereunder as noted on the stock ledger of the Company;
and
(v) the delivery by the Selling Stockholders to the several
Underwriters of certificates for the Shares being sold hereunder by the
Selling Stockholders against payment therefor as provided herein, will
convey good and marketable title to such Shares to the several
Underwriters, free and clear of all security interests, liens,
encumbrances, equities, claims or other defects (assuming the several
Underwriters have purchased such Shares in good faith and without notice
of any security interests, liens, encumbrances, equities, claims or other
defects within the meaning of the Uniform Commercial Code).
The opinion of such counsel may state that, as to factual matters, such
counsel has relied upon the representations and warranties made by the
Selling Stockholders in this Agreement and that nothing has come to such
counsel's attention that causes such counsel to believe that such
representations and
14
<PAGE>
warranties included any untrue statement of a material fact or omitted to
state any material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not
misleading.
(e) The Representatives shall have received an opinion, dated such
Closing Date, of Mayer, Brown & Platt, counsel for the Underwriters, with
respect to the issuance and sale of the Shares to be delivered on such
Closing Date, the Registration Statement and the Prospectus, and such other
related matters as the Representatives may reasonably require, and the
Company shall have furnished to such counsel such documents as they may
reasonably request for the purpose of enabling them to pass upon such
matters.
(f) The Representatives shall have received from Ernst & Young LLP a
letter or letters dated, respectively, the date hereof and such Closing
Date, in form and substance satisfactory to the Representatives, as are
contemplated by AICPA Statement on Auditing Standards No. 72.
(g) The Representatives shall have received a certificate, dated such
Closing Date, of the principal executive officer and the principal financial
or accounting officer of the Company to the effect that:
(i) the representations and warranties of the Company in this
Agreement are true and correct as if made on and as of such Closing Date;
the Registration Statement, as amended as of such Closing Date, does not
include any untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein not misleading,
and the Prospectus, as amended or supplemented as of such Closing Date,
does not include any untrue statement of a material fact or omit to state
any material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading; and the Company has performed all covenants and agreements
and satisfied all conditions on its part to be performed or satisfied at
or prior to such Closing Date;
(ii) no stop order suspending the effectiveness of the Registration
Statement or any amendment thereto has been issued, and no proceedings
for that purpose have been instituted or threatened or, to the best of
the Company's knowledge, are contemplated by the Commission; and
(iii) subsequent to the respective dates as of which information is
given in the Registration Statement and the Prospectus, neither the
Company nor any of its subsidiaries has sustained any material loss or
interference with their respective businesses or properties from fire,
flood, hurricane, accident or other calamity, whether or not covered by
insurance, or from any labor dispute or any legal or governmental
proceeding, and there has not been any material adverse change, or any
development involving a prospective material adverse change, in or
affecting the condition (financial or otherwise), earnings, business or
prospects of the Company and its subsidiaries taken as a whole, except in
each case as described in the Prospectus (exclusive of any amendment or
supplement thereto).
(h) The Representatives shall have received from each Selling
Stockholder a certificate dated the Firm Closing Date, to the effect that:
(i) The representations and warranties of such Selling Stockholder
in this Agreement are true and correct, as if made at and as of such
Closing Date, and such Selling Stockholder has complied with all the
agreements and satisfied all the conditions to be performed or satisfied
by such Selling Stockholder at or prior to such Closing Date.
(ii) Such Selling Stockholder, after a careful examination of the
Registration Statement, but without independent investigation to
determine the accuracy or completeness of the information contained in
the Registration Statement or any amendment thereof, and based upon the
discussions, if any, such Selling Stockholder has had with officers and
other representatives of the Company and the information regarding the
Company, if any, that has been furnished to the Selling Stockholder,
15
<PAGE>
does not know of an untrue statement of a material fact included in the
Registration Statement or the omission from the Registration Statement of
any material fact required to be stated therein or necessary to make the
statements therein not misleading.
(i) On or before the Firm Closing Date, the Representatives and counsel
for the Underwriters shall have received such further certificates,
documents or other information as they may have reasonably requested from
the Company and the Selling Stockholders.
(j) Prior to the commencement of the offering of the Shares, the Shares
shall have been listed for trading on the NYSE.
(k) (i) The Representatives shall have received from each person who
is an executive officer of the Company an agreement to the effect that such
person will not, directly or indirectly, without the prior written consent
of Lazard Freres & Co. LLC, on behalf of the Underwriters, offer, sell,
offer to sell, contract to sell, pledge, grant any option to purchase, or
otherwise sell or dispose (or announce any offer, sale, offer of sale,
contract of sale, pledge, grant of an option to purchase or other sale or
disposition) of any shares of capital stock of the Company or any securities
convertible into, or exchangeable or exercisable for, shares of, capital
stock of the Company for a period of 180 days after the date of this
Agreement; and
(ii) The Representatives shall have received from each person who is an
outside director of the Company an agreement to the effect that such person
will not, directly or indirectly, without the prior written consent of
Lazard Freres & Co. LLC, on behalf of the Underwriters, offer, sell, offer
to sell, contract to sell, pledge, grant any option to purchase, or
otherwise sell or dispose (or announce any offer, sale, offer of sale,
contract of sale, pledge, grant of an option to purchase or other sale or
disposition) of any shares of capital stock of the Company or any securities
convertible into, or exchangeable or exercisable for, shares of capital
stock of the Company for a period of 90 days after the date of this
Agreement.
All opinions, certificates, letters and documents delivered pursuant to this
Agreement will comply with the provisions hereof only if they are reasonably
satisfactory in all material respects to the Representatives and counsel for the
Underwriters. The Company and the Selling Stockholders shall furnish to the
Representatives such conformed copies of such opinions, certificates, letters
and documents in such quantities as the Representatives and counsel for the
Underwriters shall reasonably request.
The respective obligations of the several Underwriters to purchase and pay
for any Option Shares shall be subject, in their discretion, to each of the
foregoing conditions to purchase the Firm Shares, except that all references to
the Firm Shares and the Firm Closing Date shall be deemed to refer to such
Option Shares and the related Option Closing Date, respectively.
10. INDEMNIFICATION AND CONTRIBUTION. (a) The Company agrees to indemnify
and hold harmless each Underwriter and each person, if any, who controls any
Underwriter within the meaning of either Section 15 of the Act or Section 20 of
the Exchange Act, from and against any and all losses, claims, damages and
liabilities (or actions in respect thereof) (including, without limiting the
foregoing, the reasonable legal and other expenses incurred in connection with
investigating or defending or preparing to defend or appearing as a third party
witness in connection with any such loss, claim, damage, liability or action, as
such expenses are incurred) arising out of or based on any untrue statement or
alleged untrue statement of a material fact contained in the Registration
Statement or the Prospectus or any Preliminary Prospectus, or caused by any
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading,
except insofar as such losses, claims, damages, liabilities or expenses are
caused by any such untrue statement or omission or alleged untrue statement or
omission based upon information furnished to the Company in writing by an
Underwriter through the Representatives specifically for inclusion therein. This
indemnity agreement will be in addition to any liability which the Company may
otherwise have to the persons referred to above in this Section 10(a).
(b) Each Selling Stockholder agrees, severally and not jointly, to indemnify
and hold harmless each Underwriter and each person, if any, who controls any
Underwriter within the meaning of either Section 15 of
16
<PAGE>
the Act or Section 20 of the Exchange Act and the Company, its directors, its
officers who sign the Registration Statement and each person, if any, who
controls the Company within the meaning of either such Section, from and against
any and all losses, claims, damages and liabilities (or actions in respect
thereof) (including, without limiting the foregoing, the reasonable legal and
other expenses incurred in connection with investigating or defending or
preparing to defend or appearing as a third party witness in connection with any
such loss, claim, damage liability or action, as such expenses are incurred)
caused by any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement or the Prospectus or any Preliminary
Prospectus or caused by any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as such losses, claims, damages,
liabilities or expenses are caused by any such untrue statement or omission or
alleged untrue statement or omission based upon information furnished to the
Company by an Underwriter through the Representatives specifically for inclusion
therein. This indemnity agreement will be in addition to any liability which the
Selling Stockholders may otherwise have to the persons referred to above in this
Section 10(b).
(c) Each Underwriter agrees, severally and not jointly, to indemnify and
hold harmless the Company, the Selling Stockholders, the directors of the
Company, the officers of the Company who sign the Registration Statement and
each person, if any, who controls the Company or any Selling Stockholder within
the meaning of either Section 15 of the Act or Section 20 of the Exchange Act
from and against any and all losses, claims, damages and liabilities (or actions
in respect thereof) caused by any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement or the Prospectus or
any Preliminary Prospectus, or caused by any omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make
the statements therein not misleading but only with reference to information
furnished to the Company by an Underwriter through the Representatives
specifically for inclusion therein. This indemnity agreement will be in addition
to any liability which the Underwriters may otherwise have to the persons
referred to above in this Section 10(c).
(d) In case any action or proceeding (including any governmental or
regulatory investigation or proceeding) shall be instituted involving any person
in respect of which indemnity may be sought pursuant to any of the three
preceding paragraphs, such person (hereinafter called the indemnified party)
shall promptly notify the person against whom such indemnity may be sought
(hereinafter called the indemnifying party) in writing; however, the omission to
so notify the indemnifying party shall relieve the indemnifying party from
liability under the three preceding paragraphs only to the extent prejudiced
thereby. The indemnifying party, upon request of the indemnified party, shall
assume the defense thereof, including the employment of counsel reasonably
satisfactory to the indemnified party to represent the indemnified party and any
others that the indemnifying party may designate and shall pay the fees and
disbursements of such counsel related to such proceeding. In any such action or
proceeding any indemnified party shall have the right to retain its own counsel,
but the fees and expenses of such counsel shall be at the expense of such
indemnified party unless (i) the indemnifying party and the indemnified party
shall have mutually agreed to the retention of such counsel or (ii) the named
parties to any such proceeding (including any impleaded parties) include both
the indemnifying party and the indemnified party and representation of both
parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood that the indemnifying party
shall not, in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for (a) the reasonable fees and expenses of more than
one separate firm (in addition to any local counsel) for all Underwriters and
all persons, if any, who control Underwriters within the meaning of either
Section 15 of the Act or Section 20 of the Exchange Act, (b) the reasonable fees
and expenses of more than one separate firm (in addition to any local counsel)
for the Company, its directors, its officers who sign the Registration Statement
and each person, if any, who controls the Company within the meaning of either
such Section and (c) the reasonable fees and expenses of more than one separate
firm (in addition to any local counsel) for all Selling Stockholders and all
persons, if any, who control Selling Stockholders within the meaning of either
such Section, and that all such fees and expenses shall be reimbursed as they
are incurred. In the case of any such separate firm for the Underwriters and
such control persons of Underwriters, such firm shall be designated in writing
by Lazard Freres & Co. In the case of any such separate firm for the Company,
and such directors,
17
<PAGE>
officers and control persons of the Company, such firm shall be designated in
writing by the Company. In the case of any such separate firm for the Selling
Stockholders and such controlling persons of Selling Stockholders, such firm
shall be designated in writing by the individual Selling Stockholder.
(e) If the indemnification provided for in this Section 10 is insufficient
or unavailable to an indemnified party in respect of any losses, claims, damages
or liabilities (or actions in respect thereof) referred to therein, then each
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities and expenses (i) in such proportion
as is appropriate to reflect the relative benefits received by the Company and
the Selling Stockholders, on the one hand, and the Underwriters, on the other,
from the offering of the Shares or (ii) if the allocation provided by clause (i)
above is not permitted by applicable law or if the indemnified party shall have
failed to the prejudice of the indemnifying party to give the notice required by
Section 10(d), in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of
the Company and the Selling Stockholders, on the one hand, and the Underwriters,
on the other, in connection with the statements or omissions which resulted in
such losses, claims, damages, liabilities or expenses, as well as any other
relevant equitable considerations. The relative benefits received by the Company
and the Selling Stockholders, on the one hand, and the Underwriters, on the
other, shall be deemed to be in the same proportions as the total net proceeds
from the offering (before deducting expenses) received by the Company and the
Selling Stockholders bear to the total underwriting discounts and commissions
received by the Underwriters, in each case as set forth in the table on the
cover page of the Prospectus. The relative fault of the Company and the Selling
Stockholders, on the one hand, and the Underwriters, on the other, shall be
determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or the Selling
Stockholders, on the one hand, or by the Underwriters, on the other, and the
parties, relative intent, knowledge, access to information and opportunity to
correct or prevent such statement or omission.
(f) The Company, the Selling Stockholders and the Underwriters agree that
it would not be just and equitable if contribution pursuant to Section 10(e)
were determined by pro rata allocation (even if the Underwriters were treated as
one entity for such purpose) or by any other method of allocation which does not
take account of the equitable considerations referred to in the immediately
preceding paragraph. The amount paid or payable by an indemnified party as a
result of the losses, claims, damages or liabilities (of actions in respect
thereof) referred to in the immediately preceding paragraph shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of Section 10(e), in no event shall any
Underwriter be required to contribute any amount in excess of the amount by
which the total price at which the Shares underwritten by it and distributed to
the public were offered to the public exceeds the amount of any damages which
such Underwriter has otherwise been required to pay by reason of such untrue or
alleged statement or omission or alleged omission. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Act)
shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Underwriters, obligations to contribute
pursuant to Section 10(e) are several in proportion to the respective number of
Firm Shares set forth opposite their names in Schedule 1 hereto and not joint.
(g) The Company and the Selling Stockholders agree that any claims that the
Company may have against any Selling Stockholder and any claims that any Selling
Stockholder may have against the Company in each case arising out of or based on
any untrue statement or alleged untrue statement in the Registration Statement
or the Prospectus or any Preliminary Prospectus, or caused by any omission or
alleged omission to state therein a material fact, or otherwise arising out of
or based upon the sale of Shares (each a "Cross-Claim"), shall be subordinated
in right of payment as set forth below to the prior indefeasible payment in full
in cash of any and all claims the Underwriters may have against any of the
Selling Stockholders or the Company, as the case may be, arising out of or based
on any untrue statement or alleged untrue statement in the Registration
Statement or
18
<PAGE>
the Prospectus or any Preliminary Prospectus, or caused by any omission or
alleged omission to state therein a material fact, or otherwise arising out of
or based upon the sale of Shares under this Agreement (each a "Underwriter
Claim"). The Company and each Selling Stockholder agree that it will provide
notice to you within three business days of the making by it of any Cross-Claim,
and that such notice shall provide reasonable detail as to the factual and legal
basis for the Cross-Claim and the amount claimed. Thereafter, no amount may be
paid by the Company or any Selling Stockholder in respect of any such
Cross-Claim until the date that is 45 days after the receipt by you of the
foregoing notice; PROVIDED, HOWEVER, that if any Underwriter shall have prior to
such 45th day notified the Company or such Selling Stockholder, as the case may
be, who made such Cross-Claim or against whom such Cross-Claim was made of any
Underwriter Claim that such Underwriter is making or may make against it, then
no amount may be paid by the Company or such Selling Stockholder with respect to
such Cross-Claim without the prior written approval of each such Underwriter
until the prior indefeasible payment in full in cash of each such Underwriter
Claim or until it has been established in a final adjudication by a court of
competent jurisdiction that such Underwriter is not entitled to receive any
payment from the Company or such Selling Stockholder in respect of such
Underwriter Claim. If a payment or distribution is made to the Company or a
Selling Stockholder that because of this Section 10(g) should not have been made
to it, the Company or such Selling Stockholder receiving such payment or
distribution shall hold it in trust for the Underwriters and pay it over to them
or their designees as their interests shall appear.
(h) The Company and the Selling Stockholders agree with the Underwriters
that any indemnity provision of any agreement between the Company on the one
hand and any of the Selling Stockholders on the other shall not be deemed to
modify or supersede any provision of this Section 10.
11. DEFAULT. If, on the Firm Closing Date or the Option Closing Date, as
the case may be, any one or more of the Underwriters shall fail or refuse to
purchase Shares that it or they have agreed to purchase hereunder on such date,
and the aggregate number of Shares which such defaulting Underwriter or
Underwriters agreed but failed or refused to purchase is not more than one-tenth
of the aggregate number of the Shares to be purchased on such date, the other
Underwriters shall be obligated severally in the proportions that the number of
Firm Shares set forth opposite their respective names in Schedule 1 bear to the
aggregate number of Firm Shares set forth opposite the names of all such
non-defaulting Underwriters, or in such other proportions as you may specify, to
purchase the Shares which such defaulting Underwriter or Underwriters agreed but
failed or refused to purchase on such date; PROVIDED that in no event shall the
number of Shares that any Underwriter has agreed to purchase pursuant to Section
4 be increased pursuant to this Section 11 by an amount in excess of one-ninth
of such number of Shares without the written consent of such Underwriter. If, on
the Firm Closing Date or the Option Closing Date, as the case may be, any
Underwriter or Underwriters shall fail or refuse to purchase Shares and the
aggregate number of Shares with respect to which such default occurs is more
than one-tenth of the aggregate number of Shares to be purchased an such date,
and arrangements satisfactory to you, the Company and the Selling Stockholders
for the purchase of such Shares are not made within 36 hours after such default,
this Agreement shall terminate without liability on the part of any non-
defaulting Underwriter or the Company or the Selling Stockholders. In any such
case either you or the Company shall have the right to postpone the Firm Closing
Date or the Option Closing Date, as the case may be, but in no event for longer
than seven days, in order that the required changes, if any, in the Registration
Statement and in the Prospectus or in any other documents or arrangements may be
effected. Any action taken under this paragraph shall not relieve any defaulting
Underwriter from liability in respect of any default of such Underwriter under
this Agreement.
12. SURVIVAL. All representations, warranties and agreements contained in
the Agreement, or contained in certificates of officers of the Company or of a
Selling Stockholder submitted pursuant hereto, including indemnification and
contribution agreements, shall remain operative and in full force and effect
regardless of any termination of this Agreement, or any investigation, or any
statement as to the results thereof made by or on behalf of any Underwriter or
any person controlling any Underwriter or by or on behalf of the Company, its
officers or directors or controlling persons, or by any Selling Stockholder or
any person controlling any Selling Stockholder, and shall survive acceptance of
and payment for the Shares hereunder.
19
<PAGE>
13. TERMINATION. (a) This Agreement may be terminated with respect to the
Firm Shares or any Option Shares in the sole discretion of the Representatives
by notice to the Company and the Selling Stockholders given prior to the Firm
Closing Date or the related Option Closing Date, respectively, in the event that
the Company or a Selling Stockholder shall have failed, refused or been unable
to perform all obligations and satisfy all conditions on its part to be
performed or satisfied hereunder at or prior thereto or, if at or prior to the
Firm Closing Date or such Option Closing Date, respectively, (i) the Company and
its subsidiaries taken as a whole shall have, in the sole judgment of the
Representatives, sustained any material loss or interference with their
respective businesses or properties from fire, flood, hurricane, accident or
other calamity, whether or not covered by insurance, or from any labor dispute
or any legal or governmental proceeding or there shall have been any material
adverse change in the condition (financial or otherwise), earnings, business or
prospects of the Company and its subsidiaries taken as a whole, whether or not
arising in the ordinary course of business, except in each case as described in
the Prospectus (exclusive of any amendment or supplement thereto); (ii) trading
in the Common Stock shall have been suspended by the Commission or the NYSE or
trading in securities generally on the NYSE or the Nasdaq National Market shall
have been suspended or minimum or maximum prices shall have been established on
such exchange or market system; (iii) a banking moratorium shall have been
declared by New York or United States authorities; or (iv) there shall have been
an outbreak or escalation of hostilities or other calamity or crisis or material
adverse change in existing national or international financial, political,
economic or securities market conditions, the effect of which is such as to make
it, in the sole judgment of Lazard Freres & Co. LLC, impractical or inadvisable
to proceed with the public offering or delivery of the Shares as contemplated by
the Registration Statement, as amended as of the date hereof.
(b) Termination of this Agreement pursuant to this Section 13 shall be
without liability of any party to any other party except as provided in Section
12 hereof.
(c) In the event of any such termination, the provisions of Section 8
(EXPENSES), Section 10 (INDEMNIFICATION AND CONTRIBUTION), and the provisions of
Sections 12 (SURVIVAL) and 17 (GOVERNING LAW) shall remain in effect.
14. INFORMATION SUPPLIED BY UNDERWRITERS. The statements set forth in the
last paragraph on the front cover page and under the heading "Underwriting" in
any Preliminary Prospectus or the Prospectus (to the extent such statements
relate to the Underwriters) constitute the only information furnished to the
Company by an Underwriter through the Representatives specifically for inclusion
in the Registration Statement, the Prospectus or any Preliminary Prospectus for
the purposes of Sections 2(b) and 10 hereof. The Underwriters confirm that such
statements (to such extent) are correct.
15. NOTICES. All notices and other communications hereunder shall be in
writing and shall be deemed to have been duly given if mailed or transmitted by
any standard form of telecommunication. Notices to the Underwriters shall be
directed to you c/o Lazard Freres & Co. LLC, 30 Rockefeller Plaza, New York, NY
10020, Attention: Syndicate Department; notices to the Company and the Selling
Stockholders shall be directed to them c/o Shelby Williams Industries, Inc.,
11-111 Merchandise Mart, Chicago, Illinois 60654, Attention: Chairman of the
Executive Committee.
16. SUCCESSORS. This Agreement shall inure to the benefit of and shall be
binding upon the several Underwriters, the Company, the Selling Stockholders,
any controlling persons referred to herein and their respective heirs, assigns,
successors and legal representatives. Nothing expressed or mentioned in this
Agreement is intended or shall be construed to give any other person, firm or
corporation any legal or equitable right, remedy or claim under or in respect of
this Agreement or any provisions herein contained. No purchaser of Shares from
any Underwriter shall be deemed a successor because of such purchase.
17. GOVERNING LAW. This Agreement shall be governed by, and construed in
accordance with, the law of the State of New York.
18. COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.
20
<PAGE>
If the foregoing correctly sets forth our understanding, please indicate
your acceptance thereof in the space provided below for that purpose, whereupon
this letter shall constitute an agreement binding the Company, the Selling
Stockholders and each of the several Underwriters.
Very truly yours,
SHELBY WILLIAMS INDUSTRIES, INC.
By: PAUL N. STEINFELD
-----------------------------------
Name: Paul N. Steinfeld
Title: Chairman of the Board
SELLING STOCKHOLDERS:
MANFRED STEINFELD
--------------------------------------
Manfred Steinfeld
THE FERN AND MANFRED STEINFELD
CHARITABLE REMAINDER TRUST
By: MANFRED STEINFELD, Trustee
MANFRED STEINFELD
--------------------------------------
Manfred Steinfeld
The foregoing Agreement is hereby
confirmed and accepted as of the date
first above written.
LAZARD FRERES & CO. LLC
INTERSTATE/JOHNSON LANE CORPORATION
By: LAZARD FRERES & CO. LLC
By: JEFFREY A. GOLMAN
-----------------------------------
Name: Jeffrey A. Golman
Title: Managing Director
For itself and on behalf of the
Representatives
21
<PAGE>
SCHEDULE 1
<TABLE>
<CAPTION>
NUMBER OF
NUMBER OF SELLING
COMPANY STOCKHOLDER
NAME OF UNDERWRITER FIRM SHARES FIRM SHARES
- --------------------------------------------------------------------------------------- ----------- -----------
<S> <C> <C>
Lazard Freres & Co. LLC................................................................ 227,600 572,400
Interstate/Johnson Lane Corporation.................................................... 227,600 572,400
Bear, Stearns & Co. Inc................................................................ 11,380 28,620
Alex. Brown & Sons Incorporated........................................................ 11,380 28,620
Dillon, Read & Co. Inc................................................................. 11,380 28,620
A.G. Edwards & Sons, Inc............................................................... 11,380 28,620
Merrill Lynch, Pierce, Fenner & Smith Incorporated..................................... 11,380 28,620
Allen & Company Incorporated........................................................... 5,690 14,310
Robert W. Baird & Co. Incorporated..................................................... 5,690 14,310
BlueStone Capital Partners, L.P........................................................ 5,690 14,310
Cleary Gull Reiland & McDevitt Inc..................................................... 5,690 14,310
Everen Securities, Inc................................................................. 5,690 14,310
First Albany Corporation............................................................... 5,690 14,310
Edward D. Jones & Co., L.P............................................................. 5,690 14,310
Morgan Keegan & Company, Inc........................................................... 5,690 14,310
Raymond James & Associates, Inc........................................................ 5,690 14,310
Wheat First Butcher Singer............................................................. 5,690 14,310
----------- -----------
Total.............................................................................. 569,000 1,431,000
----------- -----------
----------- -----------
</TABLE>
S-1-1
<PAGE>
SCHEDULE 2
<TABLE>
<CAPTION>
NUMBER OF
NAME OF SELLING STOCKHOLDER FIRM SHARES
- ----------------------------------------------------------------------------------------------------- -----------
<S> <C>
Manfred Steinfeld.................................................................................... 1,100,000
The Fern and Manfred Steinfeld
Charitable Remainder Trust......................................................................... 331,000
-----------
Total.............................................................................................. 1,431,000
-----------
-----------
</TABLE>
S-2-1
<PAGE>
EXHIBIT 2
March 4, 1997
Lazard Freres & Co. LLC
Interstate/Johnson Lane Corporation
As representatives of the Several Underwriters
c/o Lazard Freres & Co. LLC
30 Rockefeller Plaza
New York, NY 10020
Gentlemen:
Each of the undersigned is a director or officer and stockholder of Shelby
Williams Industries, Inc., a Delaware corporation ("Shelby"), and is desirous of
facilitating the public offering of certain of the shares of Shelby common stock
owned by Manfred Steinfeld, individually and as Trustee, and the sale of
additional shares of Shelby by Shelby itself. Each of the undersigned
recognizes that such offering will increase the float for the shares of Shelby
common stock created thereby and will increase the equity of Shelby, all of
which will be of benefit to the undersigned.
In consideration of the foregoing, the undersigned and each of them hereby
confirm and agree that they will not, without the prior written approval of
Lazard Freres & Co. LLC, directly or indirectly, offer, sell, offer to sell,
contract to sell, pledge, grant any option to purchase, or otherwise sell or
dispose (or announce any offer, sale, offer of sale, contract of sale, pledge,
grant of an option to purchase or other sale or disposition) of any shares of
capital stock of Shelby or any securities convertible into, or exchangeable or
exercisable for, shares of capital stock of Shelby for a period of 180 days
following the date of the Prospectus relating to the offering.
This agreement shall be binding on the undersigned and their respective
successors, heirs, personal representatives and assigns.
This agreement may be executed in one or more counterparts, each of which
shall be deemed an original but all of which, when deemed together, shall be and
constitute one original.
PAUL N. STEINFELD s/ Paul N. Steinfeld
------------------------
ROBERT P. COULTER s/ Robert P. Coulter
------------------------
MANFRED STEINFELD s/ Manfred Steinfeld
------------------------
PETER W. BARILE s/ Peter W. Barile
------------------------
SAM FERRELL s/ Sam Ferrell
------------------------
